Abbott Laboratories (Pakistan) Limited (PSX:ABOT)
909.91
-14.55 (-1.57%)
At close: Mar 27, 2026
PSX:ABOT Balance Sheet
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 13,338 | 6,182 | 5,037 | 7,966 | 819.35 |
Short-Term Investments | - | - | - | 825.8 | 7,800 |
Cash & Short-Term Investments | 13,338 | 6,182 | 5,037 | 8,792 | 8,619 |
Cash Growth | 115.74% | 22.75% | -42.71% | 2.00% | 15.10% |
Accounts Receivable | 2,821 | 3,135 | 1,650 | 1,358 | 1,295 |
Other Receivables | 1,005 | 1,498 | 2,430 | 1,329 | 741.78 |
Receivables | 4,225 | 4,686 | 4,123 | 2,720 | 2,070 |
Inventory | 13,118 | 11,224 | 13,290 | 8,856 | 7,006 |
Prepaid Expenses | - | 93.42 | 156.09 | 262.2 | 70.31 |
Other Current Assets | 313.55 | 1,076 | 593.62 | 1,199 | 666.78 |
Total Current Assets | 30,993 | 23,262 | 23,199 | 21,829 | 18,432 |
Property, Plant & Equipment | 15,636 | 14,253 | 13,375 | 11,989 | 10,006 |
Other Intangible Assets | 0.83 | 1.25 | 12.68 | 26.9 | 49.02 |
Other Long-Term Assets | 45.02 | 23.69 | 13.49 | 11.74 | 12.1 |
Total Assets | 46,816 | 37,651 | 36,693 | 33,920 | 28,568 |
Accounts Payable | 12,199 | 2,054 | 2,015 | 2,045 | 1,328 |
Accrued Expenses | 701.02 | 6,233 | 4,936 | 4,212 | 4,587 |
Short-Term Debt | - | - | - | - | 15.78 |
Current Portion of Leases | 158.3 | 22.68 | 105.99 | 120.21 | 93.74 |
Current Income Taxes Payable | 246.96 | - | - | - | - |
Current Unearned Revenue | - | 394.39 | 610.97 | 565.96 | 460.42 |
Other Current Liabilities | 71.16 | 2,956 | 9,167 | 7,664 | 2,858 |
Total Current Liabilities | 13,376 | 11,660 | 16,835 | 14,607 | 9,343 |
Long-Term Leases | 329.68 | 29.55 | 52.23 | 127.08 | 133.94 |
Pension & Post-Retirement Benefits | 494.94 | 1,184 | 1,049 | 1,580 | 1,466 |
Long-Term Deferred Tax Liabilities | 989.97 | 1,053 | 519.57 | 499.66 | 269.74 |
Total Liabilities | 15,191 | 13,927 | 18,456 | 16,814 | 11,213 |
Common Stock | 979 | 979 | 979 | 979 | 979 |
Retained Earnings | 28,573 | 20,995 | 15,821 | 15,068 | 15,483 |
Comprehensive Income & Other | 2,074 | 1,750 | 1,437 | 1,059 | 892.15 |
Shareholders' Equity | 31,625 | 23,725 | 18,237 | 17,106 | 17,355 |
Total Liabilities & Equity | 46,816 | 37,651 | 36,693 | 33,920 | 28,568 |
Total Debt | 487.98 | 52.23 | 158.22 | 247.29 | 243.46 |
Net Cash (Debt) | 12,850 | 6,130 | 4,878 | 8,545 | 8,376 |
Net Cash Growth | 109.61% | 25.66% | -42.91% | 2.01% | 25.53% |
Net Cash Per Share | 131.25 | 62.62 | 49.83 | 87.28 | 85.56 |
Filing Date Shares Outstanding | 97.93 | 97.9 | 97.9 | 97.9 | 97.9 |
Total Common Shares Outstanding | 97.93 | 97.9 | 97.9 | 97.9 | 97.9 |
Working Capital | 17,617 | 11,601 | 6,364 | 7,222 | 9,089 |
Book Value Per Share | 322.94 | 242.33 | 186.28 | 174.73 | 177.27 |
Tangible Book Value | 31,625 | 23,723 | 18,225 | 17,079 | 17,306 |
Tangible Book Value Per Share | 322.94 | 242.32 | 186.16 | 174.45 | 176.77 |
Land | - | 23.4 | 23.4 | 23.4 | 23.4 |
Buildings | - | 1,012 | 1,055 | 786.79 | 582.35 |
Machinery | - | 20,385 | 18,096 | 17,018 | 14,207 |
Construction In Progress | - | 2,859 | 2,804 | 1,860 | 1,726 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.